Complete Barrett’s excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture

Background and study aims: Complete Barrett’s excision (CBE) of short-segment Barrett’s high grade dysplasia (HGD) and early esophageal adenocarcinoma by stepwise endoscopic resection is a precise staging tool, detects covert synchronous disease, and may produce a sustained treatment response. Esophageal stricture is the most commonly reported complication of CBE although risk factors have not yet been clearly defined.

Patients and methods: Data were recorded prospectively on patients with limited co-morbidity and age ≤ 80 years undergoing CBE for histologically proven HGD or esophageal adenocarcinoma within ≤ C3M5 segments. Endoscopic resection was performed by standardized protocol every 6 – 8 weeks until CBE was achieved. Esophageal dilation was performed when patients reported dysphagia. Dysphagia scores were recorded at scheduled endoscopic surveillance or by telephone interview.

Results: By intention-to-treat analysis, complete eradication of neoplasia and intestinal metaplasia was achieved in 95 % and 82 %, respectively, in 77 patients undergoing a median of 2 resection sessions (interquartile range [IQR] 1 – 3). Esophageal dilation was required in 33 % (median 3 dilations, IQR 1 – 3.5) at median follow-up of 20 months (IQR 6 – 40). Independent risk factors for dilation requirement were the number of mucosal resections at the index procedure (odds ratio [OR] 1.3 per resection, 95 % confidence interval [CI] 1.0 – 1.9; P = 0.043) and maximal extent of the Barrett’s segment (OR 2.2 per cm, 95 %CI 1.2 – 3.9; P = 0.009).

Conclusions: Although CBE is highly effective in the treatment of Barrett’s HGD and esophageal adenocarcinoma, the risk of post-CBE dysphagia increases with the maximal extent of the Barrett’s segment and the number of mucosal resections at the index procedure. These data could be used to inform treatment decisions and identify those patients who may benefit from prophylactic therapies such as dilation.

• References

• 1 Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-146
• 2 Birkmeyer JD, Siewers AE, Finlayson EV et al Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137
• 3 Birkmeyer JD, Stukel TA, Siewers AE et al Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349: 2117-2127
• 4 Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett’s oesophagus. Br J Surg 1997; 84: 1470-1473
• 5 Thomas P, Doddoli C, Neville P et al Esophageal cancer resection in the elderly. Eur J Cardiothorac Surg 1996; 10: 941-946
• 6 Pech O, Behrens A, May A et al Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 2008; 57: 1200-1206
• 7 Moss A, Bourke MJ, Hourigan LF et al Endoscopic resection for Barrett’s high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol 2010; 105: 1276-1283
• 8 Soehendra N, Seewald S, Groth S et al Use of modified multiband ligator facilitates circumferential EMR in Barrett’s esophagus (with video). Gastrointest Endosc 2006; 63: 847-852
• 9 van Vilsteren FG, Pouw RE, Seewald S et al Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011; 60: 765-773
• 10 Inoue H, Endo M, Takeshita K et al A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg Endosc 1992; 6: 264-265
• 11 Szegedi L, Gal I, Kosa I, Kiss GG. Palliative treatment of esophageal carcinoma with self-expanding plastic stents: a report on 69 cases. Eur J Gastroenterol Hepatol 2006; 18: 1197-1201
• 12 Buskens CJ, Westerterp M, Lagarde SM et al Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004; 60: 703-710
• 13 Westerterp M, Koppert LB, Buskens CJ et al Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005; 446: 497-504
• 14 Alvarez Herrero L, Pouw RE, van Vilsteren FG et al Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy 2010; 42: 1030-1036
• 15 Manner H, May A, Pech O et al Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008; 103: 2589-2597
• 16 Chennat J, Konda VJ, Ross AS et al Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma – an American single-center experience. Am J Gastroenterol 2009; 104: 2684-2692
• 17 Larghi A, Lightdale CJ, Ross AS et al Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 2007; 39: 1086-1091
• 18 Peters FP, Brakenhoff KP, Curvers WL et al Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc 2008; 67: 604-609
• 19 Pouw RE, Seewald S, Gondrie JJ et al Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut 2010; 59: 1169-1177
• 20 Shaheen NJ, Sharma P, Overholt BF et al Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
• 21 Semlitsch T, Jeitler K, Schoefl R et al A systematic review of the evidence for radiofrequency ablation for Barrett’s esophagus. Surg Endosc 2010; 24: 2935-2943
• 22 Peters FP, Kara MA, Curvers WL et al Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol 2007; 19: 311-315
• 23 Peters FP, Kara MA, Rosmolen WD et al Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: a prospective study. Am J Gastroenterol 2006; 101: 1449-1457
• 24 Katada C, Muto M, Manabe T et al Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 2003; 57: 165-169
• 25 Giovannini M, Bories E, Pesenti C et al Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. . Endoscopy 2004; 36: 782-787
• 26 Seewald S, Akaraviputh T, Seitz U et al Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003; 57: 854-859